155 related articles for article (PubMed ID: 16480885)
1. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats.
Kántor O; Temel Y; Holzmann C; Raber K; Nguyen HP; Cao C; Türkoglu HO; Rutten BP; Visser-Vandewalle V; Steinbusch HW; Blokland A; Korr H; Riess O; von Hörsten S; Schmitz C
Neurobiol Dis; 2006 Jun; 22(3):538-47. PubMed ID: 16480885
[TBL] [Abstract][Full Text] [Related]
2. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease.
Nguyen HP; Kobbe P; Rahne H; Wörpel T; Jäger B; Stephan M; Pabst R; Holzmann C; Riess O; Korr H; Kántor O; Petrasch-Parwez E; Wetzel R; Osmand A; von Hörsten S
Hum Mol Genet; 2006 Nov; 15(21):3177-94. PubMed ID: 16984963
[TBL] [Abstract][Full Text] [Related]
3. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males.
Bode FJ; Stephan M; Suhling H; Pabst R; Straub RH; Raber KA; Bonin M; Nguyen HP; Riess O; Bauer A; Sjoberg C; Petersén A; von Hörsten S
Hum Mol Genet; 2008 Sep; 17(17):2595-609. PubMed ID: 18502785
[TBL] [Abstract][Full Text] [Related]
5. Altered emotional and motivational processing in the transgenic rat model for Huntington's disease.
Faure A; Höhn S; Von Hörsten S; Delatour B; Raber K; Le Blanc P; Desvignes N; Doyère V; El Massioui N
Neurobiol Learn Mem; 2011 Jan; 95(1):92-101. PubMed ID: 21111837
[TBL] [Abstract][Full Text] [Related]
6. [Behavior characterization of a model of Huntington's disease in rats, induced by quinolinic acid].
Francis L; Cruz R; Antúnez I; Rosillo JC
Rev Neurol; 2000 Jun 1-15; 30(11):1016-21. PubMed ID: 10904945
[TBL] [Abstract][Full Text] [Related]
7. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
[TBL] [Abstract][Full Text] [Related]
8. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model.
Bode FJ; Stephan M; Wiehager S; Nguyen HP; Björkqvist M; von Hörsten S; Bauer A; Petersén A
Behav Brain Res; 2009 Dec; 205(1):175-82. PubMed ID: 19573560
[TBL] [Abstract][Full Text] [Related]
9. Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes.
Ariano MA; Wagle N; Grissell AE
J Neurosci Res; 2005 Jun; 80(5):634-45. PubMed ID: 15880743
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
[TBL] [Abstract][Full Text] [Related]
11. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.
Thu DC; Oorschot DE; Tippett LJ; Nana AL; Hogg VM; Synek BJ; Luthi-Carter R; Waldvogel HJ; Faull RL
Brain; 2010 Apr; 133(Pt 4):1094-110. PubMed ID: 20375136
[TBL] [Abstract][Full Text] [Related]
12. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
Giampà C; DeMarch Z; D'Angelo V; Morello M; Martorana A; Sancesario G; Bernardi G; Fusco FR
Eur J Neurosci; 2006 Jan; 23(1):11-20. PubMed ID: 16420411
[TBL] [Abstract][Full Text] [Related]
13. Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons.
Cicchetti F; Parent A
Mov Disord; 1996 Nov; 11(6):619-26. PubMed ID: 8914086
[TBL] [Abstract][Full Text] [Related]
14. Training specificity, graft development and graft-mediated functional recovery in a rodent model of Huntington's disease.
Döbrössy MD; Dunnett SB
Neuroscience; 2005; 132(3):543-52. PubMed ID: 15837116
[TBL] [Abstract][Full Text] [Related]
15. Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice.
Denovan-Wright EM; Attis M; Rodriguez-Lebron E; Mandel RJ
J Neurosci Res; 2008 Jun; 86(8):1748-57. PubMed ID: 18293418
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
[TBL] [Abstract][Full Text] [Related]
17. Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease.
Joel D; Ayalon L; Tarrasch R; Weiner I
Mov Disord; 2003 Dec; 18(12):1499-507. PubMed ID: 14673887
[TBL] [Abstract][Full Text] [Related]
18. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel.
Cao C; Temel Y; Blokland A; Ozen H; Steinbusch HW; Vlamings R; Nguyen HP; von Hörsten S; Schmitz C; Visser-Vandewalle V
Behav Brain Res; 2006 Jun; 170(2):257-61. PubMed ID: 16569446
[TBL] [Abstract][Full Text] [Related]
19. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
Crocker SF; Costain WJ; Robertson HA
Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
[TBL] [Abstract][Full Text] [Related]
20. Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease.
Dalbem A; Silveira CV; Pedroso MF; Breda RV; Werne Baes CV; Bartmann AP; da Costa JC
Brain Res; 2005 Jun; 1047(2):148-58. PubMed ID: 15901483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
